GlassScriptPhysician profile
Albert L Lin
NPI 1669760385
$8,001.85
in general payments reported to CMS, 2019-2025
8 companies · $99.62 in 2025
The $99.62 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,874 · 2021: $1,829 · 2022: $49.49 · 2024: $150 · 2025: $99.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $150 · Food and Beverage: $99.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $150.00 |
| Food and Beverage | $99.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $7,702.74 | 2019-2021 | |
| Cardinal Health 110 LLC | $150.00 | 2024 | |
| Genentech USA, INC. | $46.98 | 2025 | Vabysmo |
| Astellas Pharma US INC | $29.28 | 2025 | Izervay |
| Abbvie INC. | $26.66 | 2022 | |
| Apellis Pharmaceuticals, INC. | $23.36 | 2025 | Syfovre |
| Glaxosmithkline, LLC. | $22.83 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.